凯龙股份：2025年前三季度净利润约1.35亿元

Group 1 - Kailong Co., Ltd. reported a revenue of approximately 2.569 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 0.03% [1] - The net profit attributable to shareholders of the listed company was approximately 135 million yuan, showing a year-on-year increase of 20.64% [1] - The basic earnings per share increased by 12.5% to 0.27 yuan [1] Group 2 - As of the report, Kailong Co., Ltd. has a market capitalization of 5.1 billion yuan [2] - The Chinese innovative drug sector has generated 80 billion US dollars in overseas licensing this year [2] - The secondary market for biomedicine is experiencing a boom, while the primary market is facing challenges in fundraising [2]